Amenta F, Gallo P, Rossodivita A, Ricci A
Dipartimento di Sanità Pubblica e Biologia Cellulare, Università Tor Vergata, Roma, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb;347(2):147-54. doi: 10.1007/BF00169260.
The effects of dopamine on the 3',5-'cyclic adenosine monophosphate (cAMP) generating system were analyzed in membrane particles from the human right and left cardiac ventricle. In addition, the pharmacological profile and the anatomical localization of dopamine receptors were assessed on frozen sections of human cardiac atrial or ventricular tissue. Dopamine increased cAMP levels, in a concentration-dependent manner, in membranes of the right and the left ventricle. These effects were abolished by the beta-adrenoceptor antagonist (-)-propranolol, but not by the D1 receptor antagonist SCH 23390 or by the non selective D1/D2 receptor antagonist haloperidol. No specific binding of the D1 receptor antagonist [3H]-SCH 23390 was noticeable within the atrial or ventricular portions of the heart examined using either radioligand binding or autoradiographic techniques. The D2 receptor antagonist [3H]-spiroperidol, in the presence of concentrations of ketanserin sufficient to block possible binding to 5-HT2 sites, was specifically bound to sections of human heart with a dissociation constant value of about 2.6 nmol/l. The highest density of [3H]-spiroperidol binding occurred in the right ventricle followed, in descending order, by the right atrium, the upper part of the left ventricle, the lower part of the left ventricle, the left atrium and the interventricular septum. The binding profile of [3H]-spiroperidol to sections of human heart was consistent with the labeling of dopamine D2 sites. Light microscope autoradiography revealed silver grains throughout the atrial and ventricular walls and these were frequently accumulated in clusters.(ABSTRACT TRUNCATED AT 250 WORDS)
在取自人心脏左右心室的膜颗粒中,分析了多巴胺对3',5'-环磷酸腺苷(cAMP)生成系统的影响。此外,在人心脏心房或心室组织的冰冻切片上评估了多巴胺受体的药理学特征和解剖定位。多巴胺以浓度依赖的方式增加了右心室和左心室膜中的cAMP水平。这些作用被β-肾上腺素能受体拮抗剂(-)-普萘洛尔消除,但未被D1受体拮抗剂SCH 23390或非选择性D1/D2受体拮抗剂氟哌啶醇消除。使用放射性配体结合或放射自显影技术,在所检查的心脏心房或心室部分内,未观察到D1受体拮抗剂[3H]-SCH 23390的特异性结合。在存在足以阻断与5-HT2位点可能结合的酮色林浓度时,D2受体拮抗剂[3H]-螺哌啶醇特异性结合于人心脏切片,解离常数约为2.6 nmol/l。[3H]-螺哌啶醇结合的最高密度出现在右心室,其次依次为右心房、左心室上部、左心室下部、左心房和室间隔。[3H]-螺哌啶醇与人心脏切片的结合情况与多巴胺D2位点的标记一致。光学显微镜放射自显影显示,银颗粒遍布心房和心室壁,且常聚集成簇。(摘要截短于250字)